Vaxcyte, Inc. (MUN:5VA)
Germany
· Delayed Price · Currency is EUR 39.40
0.00 (0.00%)
At close: Dec 5, 2025
Vaxcyte Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cost of Revenue | - | - | 75 | 23 | - | - | Upgrade
|
| Gross Profit | - | - | -75 | -23 | - | - | Upgrade
|
| Selling, General & Admin | 125.7 | 92.9 | 60.7 | 39.81 | 25.26 | 16.02 | Upgrade
|
| Research & Development | 685.86 | 476.64 | 332.34 | 169.45 | 78.41 | 73.56 | Upgrade
|
| Operating Expenses | 811.56 | 569.55 | 393.04 | 209.26 | 103.67 | 89.58 | Upgrade
|
| Operating Income | -811.56 | -569.55 | -468.04 | -232.26 | -103.67 | -89.58 | Upgrade
|
| Interest Expense | - | - | - | -0 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 129.73 | 109.99 | 62.91 | 8.36 | 0.34 | 0.24 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | 1.67 | -2.35 | Upgrade
|
| Other Non Operating Income (Expenses) | 24.64 | -4.38 | 2.87 | 0.42 | 1.59 | 2.48 | Upgrade
|
| EBT Excluding Unusual Items | -657.2 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 0 | - | Upgrade
|
| Pretax Income | -657.2 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 | Upgrade
|
| Net Income | -657.2 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 | Upgrade
|
| Net Income to Common | -657.2 | -463.93 | -402.27 | -223.49 | -100.08 | -89.22 | Upgrade
|
| Shares Outstanding (Basic) | 136 | 122 | 97 | 65 | 52 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 136 | 122 | 97 | 65 | 52 | 30 | Upgrade
|
| Shares Change (YoY) | 19.29% | 25.57% | 49.75% | 24.95% | 75.73% | 678.53% | Upgrade
|
| EPS (Basic) | -4.84 | -3.80 | -4.14 | -3.44 | -1.93 | -3.02 | Upgrade
|
| EPS (Diluted) | -4.84 | -3.80 | -4.14 | -3.44 | -1.93 | -3.02 | Upgrade
|
| Free Cash Flow | -620.73 | -571.79 | -364.67 | -176.44 | -127.95 | -47.78 | Upgrade
|
| Free Cash Flow Per Share | -4.57 | -4.69 | -3.75 | -2.72 | -2.46 | -1.62 | Upgrade
|
| EBITDA | -799.8 | -562.54 | -464.89 | -229.42 | -101.87 | -88.18 | Upgrade
|
| D&A For EBITDA | 11.76 | 7 | 3.16 | 2.83 | 1.8 | 1.41 | Upgrade
|
| EBIT | -811.56 | -569.55 | -468.04 | -232.26 | -103.67 | -89.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.